The effect of zinc supplementation on COVID-19
Not Applicable
Recruiting
- Conditions
- COVID-19.COVID-19 , virus identifiedU07.1 COVI
- Registration Number
- IRCT20210204050238N1
- Lead Sponsor
- Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 44
Inclusion Criteria
Being 20 to 60 years old
Detection of COVID-19 based on PCR test and ward admission
Willingness to participate in the study
Intravenous daily intake of 8 mg dexamethasone
Exclusion Criteria
Taking antibiotics and vitamin D.
Advanced Respiratory Distress Syndrome leading to intubation or hospitalization in the intensive care unit
History of alcohol and tobacco use
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum C-Reactive Protein level. Timepoint: The first day and the last day of the intervention. Method of measurement: blood analysis.;Serum Interleukin-6 level. Timepoint: The first day and the last day of the intervention. Method of measurement: Using blood, serum IL-6 value in Picograms per deciliter by Kit.;Blood leukocyte count. Timepoint: The first day and the last day of the intervention. Method of measurement: blood analysis.;Total Lymphocyte Count. Timepoint: The first day and the last day of the intervention. Method of measurement: blood analysis.;Absolute neutrophil count. Timepoint: The first day and the last day of the intervention. Method of measurement: blood analysis.
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie zinc's anti-inflammatory effects in SARS-CoV-2 infection?
How does zinc supplementation compare to standard-of-care treatments for managing cytokine storm in COVID-19 patients?
Are there specific biomarkers that predict response to zinc therapy in patients with U07.1 COVI-19 viral infection?
What are the potential adverse events associated with high-dose zinc supplementation in hospitalized COVID-19 patients?
How does zinc interact with other antiviral agents like remdesivir in combination therapy for SARS-CoV-2?